Leflunomide-induced interstitial pneumonitis might be a representative of disease-modifying antirheumatic drug-induced lung injury

Author： Inokuma Shigeko  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.10, Iss.4, 2011-07, pp. : 603-611

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytochrome P450 polymorphisms and drug-induced interstitial lung disease

By Schwaiblmair Martin   Behr Werner   Foerg Wolfgang   Berghaus Thomas  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 12, 2011-12 ,pp. : 1547-1560

Informa Healthcare

Access to resources Recommend Favorite

Methaemoglobinaemia associated with trimethoprim/sulfamethoxazole treatment on a background of leflunomide‐induced pneumonitis

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 45, Iss. 2, 2015-06 ,pp. : 178-181

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug-induced interstitial lung disease (ILD) associated with statins is a "rare but serious" adverse reaction

By  

Reactions Weekly, Vol. 1, Iss. 1325, 2010-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Clinically Important Drug Interactions with Disease-Modifying Antirheumatic Drugs

By Haagsma C.J.  

Drugs & Aging, Vol. 13, Iss. 4, 1998-10 ,pp. : 281-289

Adis International

Access to resources Recommend Favorite

Drug-Induced Liver Injury

By Abboud Gebran   Kaplowitz Neil  

Drug Safety, Vol. 30, Iss. 4, 2007-01 ,pp. : 277-294

Adis International

Access to resources Recommend Favorite